im体育投注规则

October 7, 2013
https://www.tripleiconsulting.com/wp-content/uploads/2013/08/pharmacy.jpg

The Food and Drug Administration Philippines recently issued a memo implementing a paperless submission of registration.  FDA Memorandum Circular 2013-038 aims to render fast, efficient, convenient and reliable frontline service.

FDA aims to have a paperless registration of product and company registration. For companies planning to register products there is an ongoing pilot test of the new process for registration to prepare the industry of the new process. Submission of application will be on schedule basis. Applicants will have to send an application for schedule of submission via email to pair@fda.gov.ph . Schedule will be set by FDA as per the quota that they will implement per Center. Technical dossier file of the product will be saved in a Universal Serial Bus (USB) or Flash drive and will be brought to FDA on the scheduled date of submission. FDA will then transfer the file on their system for process and evaluation.

Technical dossier requirements are still the same except for the Drug Product registration which FDA are now implementing the ASEAN Common Dossier Template Guideline for application of pharmaceutical product.

Full implementation of the memorandum will take effect on January 2014.

Contact us

Contact us below by filling out the form or just email us a message using the email info@tripleiconsulting.com

First Name (required)

Last Name (required)

Your Email (required)

Phone (Enter Your Phone Number if You'd Like Us to Call You)

Your Message

Enter the Captcha
Reload

友情链: IM体育数据最新版分析|预测推荐|IM体育现场视频比赛 | 2022im体育网上赛事_预测滚球_2022im体育结果回放时间 | im体育电脑版_分析官方赛事_im体育开户买球 | 2022im体育直播赛程官网|im体育的虚拟比赛技巧|2022im体育app赛事在线 | im体育电竞app|IM体育半决赛最新直播|IM体育正规版 | IM·体育平台官网_期胜负彩推荐_IM·体育盘口手机版 | 2022im体育软件注册可靠|v10.8 IOS版|2022im体育免费在线 |